La Jolla Pharmaceutical Company (LJPC) Announces First-Quarter 2013 Financial Results and Highlights Recent Corporate Progress
5/14/2013 10:22:56 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Completion of Phase 1 Portion of GCS-100 Clinical Trial in Chronic Kidney Disease
5/6/2013 11:01:03 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Orphan Designation From FDA for LJPC-6417
4/18/2013 11:08:30 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Start of Common Stock Quotation on OTCBB
4/3/2013 10:17:16 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Fourth-Quarter and Full-Year 2012 Financial Results and Highlights Recent Corporate Progress
4/2/2013 9:23:09 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces FDA Agreement With Proposed IND Submission for LJPC-501 in Hepatorenal Syndrome
3/4/2013 9:35:25 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Additional Notice of Allowance for Patent Covering Modified Pectin Compositions
2/14/2013 9:25:01 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Notice of Allowance for Patent Covering Modified Pectin Compositions
2/5/2013 10:17:36 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Corporate Update at 2013 Orlando World MoneyShow
2/1/2013 9:12:26 AM
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces First Patient Treated in Clinical Trial of GCS-100 in Chronic Kidney Disease
1/28/2013 8:48:16 AM
More...
|
|